Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Many children with alopecia areata also have other autoimmune diseases.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

FFA's causes may include environmental triggers and genetic factors.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Higher IL-21 levels may help predict alopecia areata activity.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.